anam final

Upload: hussain-azhar

Post on 07-Apr-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/4/2019 Anam Final

    1/82

    DR.ANAM NAVEED KHAN

    RESIDENT MEDICAL UNIT 4

    CHK

  • 8/4/2019 Anam Final

    2/82

    Name: Ayesha d/o Ateeq khan

    Age: 20 yrs

    Residence: Hyderabad

    Status: Unmarried

    D.O.A: 2-6-2011

  • 8/4/2019 Anam Final

    3/82

    She presented with 1 month history of.

    Swelling over both feet

    Vomiting, loose motions

    Abdominal pain

    Severe weight loss

  • 8/4/2019 Anam Final

    4/82

    1 month ago, the patient noticed swelling

    over both limbs, initially mild but gradually it

    progressed uptil thigh.

    This was followed by vomitings, 4-6/day,

    watery, non foul smelling, non bloody,

    associated with nausea, anorexia, increased

    thirst & central abdominal pain and withloose motions.

  • 8/4/2019 Anam Final

    5/82

    Loose motions were watery, 6-8/day,

    moderate in amount, non bloody, no mucus

    present, but tenesmus and fecal

    incontinence was present.

    Patient also complains of dry skin,

    generalized weakness, severe weight loss and

    bone pains.

  • 8/4/2019 Anam Final

    6/82

    Nothing significant.

  • 8/4/2019 Anam Final

    7/82

    Appetite: decreased

    Diet: normal

    Sleep: normal

    Micturation: no complains

    Bowel habits: As per presenting complains

    Addiction: nil

    Weight loss: significant loss noticed

  • 8/4/2019 Anam Final

    8/82

    K: 13 yrs

    Flow: decreased during last cycle

    Cycle: 4/30

  • 8/4/2019 Anam Final

    9/82

    No history of TB in family, parents and

    siblings alive and healthy.

  • 8/4/2019 Anam Final

    10/82

    Belongs to a poor family.

  • 8/4/2019 Anam Final

    11/82

    ABDOMEN: Pain in whole abdomen.

    CHEST: No chest pain, cough, breathlessness etc.

    CVS: No chest pain, dyspnea, PND, orthopnea orpalpitations.

    CNS: No dizziness, blackouts, limb weakness etc.

    MUSCULOSKELETAL: Generalizaed weakness, bonepains.

    GENITO-URINARY: No complains.

  • 8/4/2019 Anam Final

    12/82

    APPEARANCE:

    Young girl of good height, cachectic,

    pale, looking ill, lying on bed, conscious and

    oriented x 3 and co-operative.

    VITALS: B.P: 100/80 mm Hg

    Pulse: 92b/min

    R/R: 20/min

    Temp: Afebrile

  • 8/4/2019 Anam Final

    13/82

    Anemia ++

    Dehydration ++

    Edema ++

    Tongue dry and smooth

    Angular chelosis, dry skin

  • 8/4/2019 Anam Final

    14/82

    INSPECTION:

    Scaphoid shaped abdomen, centrally placedumbilicus, moving equally with respiration.Scratch marks all over abdomen.

    PALPATION:

    No tenderness, no visceromegaly, nolymphadenopathy. Free fluid present in flanks.

    Shifting dullness positive.

    AUSCULTATION:

    Gut sounds normal.

  • 8/4/2019 Anam Final

    15/82

    CHEST:

    NVB all over chest with no addedsounds.

    CVS:

    S1+S2 audible in all 4 areas with noadded sounds.

    CNS:

    Grossly intact but generalized reducedmuscle bulk.

  • 8/4/2019 Anam Final

    16/82

    20 yrs old Ayesha with no known comorbids

    presented with 1 month history of bilateral

    lower limbs swelling, vomiting & loose

    motions, abdominal pain & severe weightloss. On general examinaion, she was vitally

    stable, cachectic, moderately anemic &

    dehydrated. Pedal edema & signs of vitamin

    deficiency were present. Systemicexamination was significant for free fluid in

    the abdomen.

  • 8/4/2019 Anam Final

    17/82

    CBC:

    Hb = 10.1 gm%

    MCV = 96.2

    MCH = 32.2TLC = 8.6

    N = 72%

    PLTs = 140,000

    ESR:

    10 mm in 1st hr

  • 8/4/2019 Anam Final

    18/82

    UCE:

    Na+ = 140meq/l

    K+ = 3.1 meq/l

    cl- = 107meq/l

    BUN =3Creatinine + 0.5

    RBS:

    86mg%

    LFTs =

    T.bili = 0.83

    SGPT = 23

    Alk. phosohatase = 74

  • 8/4/2019 Anam Final

    19/82

    Vitamin B12=

  • 8/4/2019 Anam Final

    20/82

    PROTIEN A/G RATIO:

    Total= 4.9

    Albumin= 2.5

    Globulin= 2.4Ratio= 1.0

  • 8/4/2019 Anam Final

    21/82

    CALCIUM:

    6.5 (corrected Ca= 7.7)

    Mg=1.2 ( 1.6-2.6)

    PHOSPHATE=

    3.0 (2.7-4.5)

    PT/INR:

    1.44

  • 8/4/2019 Anam Final

    22/82

    URINE D/R:

    Sp.gravity = 1.01

    Nitrites= +ve

    Red cells= NilPus cells= 1-2

    Casts= Nil

    Bacteria= ++

  • 8/4/2019 Anam Final

    23/82

    VIRAL MARKERS:

    Hep B and Hep C negative by ICT.

  • 8/4/2019 Anam Final

    24/82

    Normal

  • 8/4/2019 Anam Final

    25/82

    ULTRASOUND ABDOMEN:

    Increased echogenicity of liver, moderate

    ascites.

    MT:

    Negative with 0 mm.

  • 8/4/2019 Anam Final

    26/82

    ASCITIC D/R:

    Appearance= turbid, blood stained

    Proteins= 1gm%Albumin= 0.8gm%

    Amylase= 12U/l

    RBC= +++WBC= 57/mm3 (lymphos: 81%)

    No organism seen----- AFB not seen

    SAAG Ratio : 1.7

  • 8/4/2019 Anam Final

    27/82

    CT SCAN ABDOMEN WITH CONTRAST:

    Normal

    MP:

    Not seen

  • 8/4/2019 Anam Final

    28/82

    OGD:

    Gastritis, lax esophageal sphincter

    Biopsies taken from antrum and D2.

  • 8/4/2019 Anam Final

    29/82

    STOOL D/R:

    ph= acidic

    mucus= NilRBC= Nil

    WBC= +/HPF

    Parasite cyst/ ova= None

  • 8/4/2019 Anam Final

    30/82

    SPUTUM AFBx 3:

    Negative

    TTG=

    IgA: 4.57 (

  • 8/4/2019 Anam Final

    31/82

    CBC repeated. Hb: 8.1

    MCV: 101

    TLC: 18.7Plts: 71,000

  • 8/4/2019 Anam Final

    32/82

    Report of blood c/s showed staph aureus

    (? Contamination).

    Report of urine c/s showed no growth.

  • 8/4/2019 Anam Final

    33/82

    COLONOSCOPY:

    Normal GI mucosa. Biopsies taken from

    sigmoid and caecum.

    Retic count:

    1.8%

  • 8/4/2019 Anam Final

    34/82

    BIOPSY FROM ANTRUM AND D2:

    Moderate chronic non specific duodenitis.

  • 8/4/2019 Anam Final

    35/82

    BIOPSY REPORT OF SIGMOID AND CAECUM:

    Mild to moderate non specific colitis.

    ESR:

    71 mm 1st hr

  • 8/4/2019 Anam Final

    36/82

    HYDROGEN BREATH TEST:

    Negative at 120 minutes

    NOTE: In malabsorption, breath hydrogen

    peaks (>20 ppm) at 60-90 min after lactose

    ingestion.

  • 8/4/2019 Anam Final

    37/82

    BARIUM STUDIES:

    Due.

    TSH:

    Awaited

  • 8/4/2019 Anam Final

    38/82

    MALABSORPTION SYNDROME

    TYPE???????

  • 8/4/2019 Anam Final

    39/82

    Defective absorption of fats, fat-soluble and other

    vitamins, proteins, carbohydrates, electrolytes, minerals

    and water.

    Most common clinical presentation is chronic diarrhea.

    Hallmark: Steatorrhea that causes excessive fecal fat

    excretion and produces nutritional deficiencies and GIsymptoms.

  • 8/4/2019 Anam Final

    40/82

    1. INTRALUMINAL DIGESTION

    2. TERMINAL DIGESTIONIn the brush border of the small intestinal mucosa

    3. TRANSEPITHELIAL TRANSPORT

    Through vessels and lymphatic channels.

  • 8/4/2019 Anam Final

    41/82

    Mechanism Specific Disease

    Maldigestion Chronic pancreatitis, cysticfibrosis, pancreatic carcinoma

    Bile Salt deficiency Cirrhosis, cholestasis, bacterialovergrowth, impaired ilealreabsorption, bile salt binders

    Inadequate Absorptive surface Massive intestinal resection,

    gastrocolic fistula, jejunoilealbypass

    Lymphatic obstruction Lymphoma, Whipples disease,intestinal lymphangiectasia

    Vascular disease Constrictive pericarditis, right-

    sided heart failure, mesentericarterial or venous insufficiency

    Mucosal disease Infection (esp.Giardia, Whipplesdisease, tropical sprue),Inflammatory diseases , radiation

    enteritis.

  • 8/4/2019 Anam Final

    42/82

    ABDOMINAL TUBERCULOSIS

  • 8/4/2019 Anam Final

    43/82

    Tuberculous abdomen is a condition in which there

    is tuberculous infection of the peritoneum or other

    organs in the abdomen.

  • 8/4/2019 Anam Final

    44/82

  • 8/4/2019 Anam Final

    45/82

    Abdominal TB is usually secondary to

    pulmonary TB.

    Radiologic evaluation often shows noevidence of lung disease.

    Active pulmonary disease is present in

  • 8/4/2019 Anam Final

    46/82

    Nonhealing ulcers of the mouth or anus.

    Difficulty swallowing with esophageal disease.

    Abdominal pain mimicking peptic ulcer diseasewith stomach or duodenal infection.

    Malabsorption with infection of the small

    intestine.

    Abdominal pain, diarrhea, or hematochezia withinfection of the colon.

  • 8/4/2019 Anam Final

    47/82

    Is the most common area of involvement

    Basis of which is the abundance of lymphoidtissue and slower rate of passage of luminal

    contents.

    However any area of GIT can be involved.

  • 8/4/2019 Anam Final

    48/82

    Natural course of gastrointestinal tuberculosis maybe:

    Ulcerative

    Hypertrophic

    Ulcero-hypertrophic

  • 8/4/2019 Anam Final

    49/82

    1. Small intestines: Ulcerative form

    2. Ileocaecal Region: Hypertrophic form

    3. Tuberculous Mesenteric Adenitis

    4. Tuberculous Peritonitis

  • 8/4/2019 Anam Final

    50/82

  • 8/4/2019 Anam Final

    51/82

    The cecum becomes conical, shrunken, and

    retracted out of the iliac fossa due to fibrosis

    within the mesocolon.

    Ileocecal valve becomes fixed, irregular,

    gaping, and incompetent.

  • 8/4/2019 Anam Final

    52/82

    Acute tuberculous peritonitis

    Chronic tuberculous peritonitis

    Tuberculous stricture of the small

    intestine causing subacute intestinal

    obstruction

    Ileo caecal tuberculosis presenting with a

    mass in the right iliac fossa

  • 8/4/2019 Anam Final

    53/82

    1. Ascitic Form

    2. Encysted Form

    3. Purulent Form

    4. Dry Plastic Adhesive Form

  • 8/4/2019 Anam Final

    54/82

    Abdominal Pain 90%

    Fever 60%

    Loss of Weight 60% Ascites 60%

    Night Sweats 37%

    Abdominal Mass 26%

  • 8/4/2019 Anam Final

    55/82

    Abdominal TB mimics any abdominal

    pathology, including cancers.

    Skin tests are suggestive, but PPD testingcan be negative especially in patients

    with weight loss or AIDS.

    AFB stain and culture yield is very low.

  • 8/4/2019 Anam Final

    56/82

    ULTRASONOGRAPHY

    CT Scan

    ENDOSCOPY, COLONOSCOPY:

    May demonstrate mucosalhyperemia, an ulcerated mass, multiple

    ulcers with steep edges and small sessilepolyps, small ulcers or erosions ordivertivcula most commonly in theileocecal region.

  • 8/4/2019 Anam Final

    57/82

    Gastrointest Endosc 2004;59:362-8.

  • 8/4/2019 Anam Final

    58/82

    Can show mucosal ulceration, thickening or stricture formation.

    In the early stages, spasm and hypermotility with edema of theileocecal valve.

    Later thickening of the ileocecal valve.

    A widely gaping ileocecal valve with narrowing of the terminalileum (Fleischner sign)

    A narrowed terminal ileum with rapid emptying of the diseasedsegment through a gaping ileocecal valve into a shortened, rigid,obliterated cecum (Stierlin sign)

  • 8/4/2019 Anam Final

    59/82

  • 8/4/2019 Anam Final

    60/82

    LAPAROSCOPY: Fluid for staining andculture and tissue for biopsy can beobtained.

    Final diagnosis by either endoscopic orsurgical biopsy.

    Biopsy reveals acid fast bacilli, caseatinggranuloma or positive cultures.

    Detection of tubercle bacilli in biopsyspecimen by PCR is the most sensitivemeans of diagnosis.

  • 8/4/2019 Anam Final

    61/82

  • 8/4/2019 Anam Final

    62/82

  • 8/4/2019 Anam Final

    63/82

    Intestinal obstruction

    Fistula formation

    Hemorrhage

  • 8/4/2019 Anam Final

    64/82

    Once diagnosed, ATT is started.

    1. Isoniazid

    2. Rifampicin3. Pyrazinamide

    4. Ethambutol

  • 8/4/2019 Anam Final

    65/82

    Diagnostic Laparoscopy or Laparotomy

    Therapeutic for:

    Relieving obstructions

    Removing Masses

    Draining Abscesses

  • 8/4/2019 Anam Final

    66/82

    Very good, if diagnosed before complications.

    Complications increase morbidity and mortality.

    Disseminated miliary TB has worse prognosis

  • 8/4/2019 Anam Final

    67/82

    The definitive diagnosis of intestinaltuberculosis is made by:

    Identification of the organism in tissue, either by

    direct visualization with an acid-fast stain.

    By culture of the excised tissue.

    By a PCR assay.

  • 8/4/2019 Anam Final

    68/82

    Can be established in:

    A patient with active pulmonary TB and

    radiologic and clinical findings that suggest

    intestinal involvement.

    Response to anti-TB therapy.

  • 8/4/2019 Anam Final

    69/82

    CELIAC DISEASE

  • 8/4/2019 Anam Final

    70/82

    Autoimmune disorder, prevalence of 0.5 to 1 percent in

    the US.

    HLA-DQ2 or HLA-DQ8.

    Inappropriate immune response to the dietary proteingluten, which is found in rye, wheat, and barley.

    Manifestations from no symptoms to overt

    malabsorption with involvement of multiple organsystems.

    Increased risk of some malignancies.

  • 8/4/2019 Anam Final

    71/82

    PREVALENCE AMONG

    RISK FACTOR THOSE WITH RISK FACTOR

    Dermatitis herpetiformis 100%

    1st degree relative with 5 to 22%

    celiac disease

    Autoimmune thyroid disease 1.5 to 14%

    Down syndrome 5 to 12%

    Turner's syndrome 2 to 10%

    Type 1 diabetic:

    Children 3 to 8%

    Adults 2 to 5%

  • 8/4/2019 Anam Final

    72/82

    Common

    Diarrhea

    Fatigue Borborygmi

    Abdominal pain

    Weight loss

    Abdominal distention Flatulence

    Uncommon

    Osteopenia/ osteoporosis

    Abnormal LFTs Vomiting

    Iron-deficiency anemia

    Neurologic dysfunction

    Constipation Nausea

    Up to 38 % Asymptomatic

  • 8/4/2019 Anam Final

    73/82

    Serum IgA endomysial Ab and IgA tissuetransglutaminase Ab ( Sensitivity andspecificity > 95%)

    Testing for gliadin antibodies is no longerrecommended because of the low sensitivityand specificity.

    The tTG antibody is the recommended singleserologic test for celiac disease screening inthe primary care setting.

  • 8/4/2019 Anam Final

    74/82

    Required to confirm the diagnosis of celiac

    disease.

    Should also be considered in patients withnegative serologic test results who are at high

    risk.

    Partial to total villous atrophy, or subtle cryptlengthening or increased epithelial

    lymphocytes.

    To avoid false-negative results, obtaining atleast four tissue samples is recommended.

  • 8/4/2019 Anam Final

    75/82

    Normal small intestine

    Celiac Disease Villous atrophy

    Normal villi

  • 8/4/2019 Anam Final

    76/82

    Gluten free diet.

    Eliminate all wheat, rye, barley and their

    derivatives.

    May take 6-12 months for intestines to heal.

  • 8/4/2019 Anam Final

    77/82

    Barley

    Barley malt/extract

    Bran

    Couscous

    Bromated or durum flour

    Enriched or Self RisingFlour

    Gram Flour

    Flour/meal

    Phosphated Flour

    Rye

    Semolina

    Triticale (cross between

    wheat/rye)

    Wheat

    Wheat Bran Wheat germ

    Wheat starch

  • 8/4/2019 Anam Final

    78/82

    Osteoporosis

    Thyroid dysfunction

    Deficiencies in folic acid, vitamin B12, fat-soluble vitamins, and iron

    Increased risk of malignancy:

    Non-Hodgkin's lymphoma (3-6x more likely)

    Oropharyngeal, esophageal, and small intestinaladenocarcinoma.

  • 8/4/2019 Anam Final

    79/82

    Protozoal infection of upper small intestine.

    Caused by flagellate Giardia lamblia.

    Most abundant in areas with poor sanitation.

    Only the cyst form is infectious, trophozoites aredestroyed by gastric acidity.

    Hypo-gammaglobulinemia, low IgA levels in gut,achlorydria, malnutrition are the favouringfactors.

  • 8/4/2019 Anam Final

    80/82

    50% , no discernable infection.

    10% , asymptomatic cyst passers.

    25-50% , acute diarrheal illness------ followed bychronic diarrhea.

    Abdominal cramps, bloating, flatulence, nausea,malaise & anorexia.

    Stools greasy & frothy with no pus, blood or mucus.

    Weight loss is common.

  • 8/4/2019 Anam Final

    81/82

    Identification of cyst or trophozoites in stool.

    Antigen assays.

  • 8/4/2019 Anam Final

    82/82

    Metronidazole

    Tinidazole

    Nitazoxanide Furazolidine

    Albendazole